S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Alexander M. Spence, MD
University of Washington
Study Chair - Deborah T. Blumenthal, MD
University of Utah
Study Chair - Keith J. Stelzer, MD, PhD
Celilo Cancer Center at Mid-Columbia Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
163 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Regional Hospital Cancer Center
Anchorage, Alaska, United States
- Banner Good Samaritan Medical Center
Phoenix, Arizona, United States
- Banner Thunderbird Medical Center
Phoenix, Arizona, United States
- Ccop - Western Regional, Arizona
Phoenix, Arizona, United States
- St. Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- North Bay Cancer Center
Fairfield, California, United States
- Memorial Hospital Cancer Center
Colorado Springs, Colorado, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- St. Anthony North Hospital
Westminster, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- West Florida Cancer Institute at West Florida Hospital - Pensacola
Pensacola, Florida, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Hematology Oncology Associates of Eastern Idaho
Idaho Falls, Idaho, United States
- Saint Anthony'S Hospital at Saint Anthony'S Health Center
Alton, Illinois, United States
- University of Illinois at Chicago Cancer Center
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago Westside Hospital
Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Good Samaritan Regional Health Center
Mount Vernon, Illinois, United States
- Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
- St. Francis Hospital and Health Centers
Beech Grove, Indiana, United States
- Genesis Medical Center - West Campus
Davenport, Iowa, United States
- Genesis Regional Cancer Center at Genesis Medical Center
Davenport, Iowa, United States
- Cancer Center of Kansas - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, P.A. - El Dorado
El Dorado, Kansas, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Veterans Affairs Medical Center - Kansas City
Kansas City, Kansas, United States
- Cancer Center of Kansas - Kingman
Kingman, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2001
- Primary completion
- 31 May 2006
- Completion
- 30 Nov 2012
- Last update posted
- 30 Jan 2013
- Registered enrollment
- 183
- Registry id
- NCT00017147
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.